Hemostaz ve Tromboz

Hoffman M, Monroe DM. A cell-based model of hemostasis. Thrombosis and Haemostasis. 2001;85(6):958-965. doi:10.1055/s-0037-1615947.

Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arteri- osclerosis, Thrombosis, and Vascular Biology. 2002;22(9):1381-1389. doi:10.1161/01. ATV.0000031340.68494.34.

Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. Phy- siological Reviews. 2013;93(1):327-358. doi:10.1152/physrev.00016.2011.

Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2018;38(4):709-725. doi:10.1161/ATVBAHA.117.309846.

Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. Journal of Thrombosis and Haemostasis. 2019;17(2):283-294. doi:10.1111/jth.14371.

Choi SJ, Lillicrap D. A sticky proposition: The endothelial glycocalyx and von Willebrand factor. J Thromb Haemost. 2020 Apr;18(4):781-785. doi: 10.1111/jth.14743. Epub 2020 Feb 26. PMID: 31984614; PMCID: PMC7594466.

Ferreira G, Taylor A, Mensah SA. Deciphering the triad of endothelial glycocalyx, von Willebrand Factor, and P-selectin in inflammation-induced coagulation. Front Cell Dev Biol. 2024 Apr 30;12:1372355. doi: 10.3389/fcell.2024.1372355. PMID: 38745860; PMCID: PMC11091309.

Gremmel T, Frelinger AL 3rd, Michelson AD. Platelet Physiology. Semin Thromb Hemost. 2024 Nov;50(8):1173-1186. doi: 10.1055/s-0044-1786387. Epub 2024 Apr 23. PMID: 38653463.

Scridon A. Platelets and their role in hemostasis and thrombosis. International Journal of Molecular Sciences. 2022;23(19):11972. doi:10.3390/ijms231911972.

Gabrilchak AI, et al. A modern overview of the process of platelet formation and maturation. 2024.

Yong J, et al. The convergent model of coagulation. Journal of Thrombosis and Haemostasis. 2024;22:.

Yong J, Toh CH. Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation. Blood. 2023 Dec 21;142(25):2133-2145. doi: 10.1182/blood.2023021166. PMID: 37890148.

Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nature Reviews Immunology. 2013;13(1):34-45. doi:10.1038/nri3345.

Almskog LM, et al. Thromboinflammation versus immunothrombosis. Frontiers in Immunology. 2025;16:1599639.

Esmon CT. The protein C pathway. Chest. 2003;124(3 Suppl):26S-32S. doi:10.1378/ chest.124.3_suppl.26S.

Mast AE. Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 2016;36(1):9-14.

Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Reviews. 2015;29(1):17-24. doi:10.1016/j.blre.2014.09.003.

Longstaff C, Kolev K. Basic mechanisms and regulation of fibrinolysis. Journal of Thrombosis and Haemostasis. 2015;13 Suppl 1:S98-S105.

Undas A, Ariëns RAS. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011;31(12):e88-e99.

Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thrombosis Research. 2007;120 Suppl 1:S5-S9.

Springer TA. von Willebrand factor, Jedi knight of the bloodstream. Blood. 2014;124(9):1412- 1425.

Grover SP, Bergmeier W, Mackman N. Platelet Signaling Pathways and New Inhibitors. Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):e28-e35. doi: 10.1161/ ATVBAHA.118.310224. PMID: 29563117; PMCID: PMC5989728.

Flaumenhaft R, Sharda A. The life cycle of platelet granules. F1000Research. 2018;7:236.

Grover SP, Mackman N. Intrinsic pathway of coagulation and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019;39(3):331-338.

Dahlbäck B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. Journal of Internal Medicine. 2005;257(3):209-223.

Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. British Journal of Haematology. 2005;129(3):307-321.

Delabranche X, et al. Evidence of netosis in septic shock-induced disseminated intravascular coagulation. Shock. 2017;47(3):313-317.

Skendros P, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. Journal of Clinical Investigation. 2020;130(11):6151-6157.

Iba T, Levy JH, Warkentin TE, et al. Diagnosis and management of sepsis-induced coagulo- pathy and disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 2019;17(11):1989-1994.

Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(36):15880-15885.

Kitchen S, Adcock DM, Dauer R, et al. International Council for Standardization in Hae- matology (ICSH) recommendations for processing of blood samples for coagulation testing. Int J Lab Hematol. 2021 Dec;43(6):1272-1283. doi: 10.1111/ijlh.13702. Epub 2021 Sep 27. PMID: 34581008.

James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diag- nosis of von Willebrand disease. Blood Adv. 2021 Jan 12;5(1):280-300. d o i : 10.1182/bloodadvances.2020003265. PMID: 33570651; PMCID: PMC7805340.

Douxfils J, Adcock DM, Bates SM, et al. 2021 update of the International Council for Standar- dization in Haematology recommendations for laboratory measurement of direct oral antico- agulants. Thrombosis and Haemostasis. 2021;121(8):1008-1020. doi:10.1055/a-1450-8178.

Gosselin RC, Adcock DM, Bates SM, et al. International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants. Th- rombosis and Haemostasis. 2018;118(3):437-450. doi:10.1055/s-0038-1627480.

Samuelson BT, Cuker A, Siegal DM, Crowther M, Garcia DA. Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review. Chest. 2017;151(1):127-138. doi:10.1016/j.chest.2016.08.1462.

Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardiza- tion Committee for lupus anticoagulant/antiphospholipid antibodies of the ISTH: update of the guidelines for lupus anticoagulant detection and interpretation. Journal of Thrombosis and Haemostasis. 2020;18(11):2828-2839. doi:10.1111/jth.15047.

Tripodi A, Cohen H, Devreese KMJ. Lupus anticoagulant detectionin anticoagulated patients: guidance from the ISTH-SSC. Journal of Thrombosis and Haemostasis. 2020;18(7):1569- 1575. doi:10.1111/jth.14846.

Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guideli- nes for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010 Dec;134(6):955-63. doi: 10.1309/ AJCP9V3RRVNZMKDS. PMID: 21088160.

Stépanian A, Fischer F, Flaujac C, et al. Light transmission aggregometry for platelet function testing: position paper on current recommendations and French proposals for accreditation. Platelets. 2024;35(1):2427745. doi:10.1080/09537104.2024.2427745.

Hartmann J, Hermelin D, Levy JH. Viscoelastic testing: an illustrated review of techno- logy and clinical applications. Res Pract Thromb Haemost. 2022 Dec 27;7(1):100031. doi: 10.1016/j.rpth.2022.100031. PMID: 36760779; PMCID: PMC9903681.

Ross JE, Mohan S, Zhang J, et al. Evaluating the clinical validity of genes related to hemosta- sis and thrombosis using the Clinical Genome Resource gene curation framework. J Thromb Haemost. 2024 Mar;22(3):645-665. doi: 10.1016/j.jtha.2023.11.011. Epub 2023 Nov 26. PMID: 38016518; PMCID: PMC10922649.

Downes K, Megy K, Duarte D, et al. Diagnostic high-throughput sequencing of 2396 pa- tients with bleeding, thrombotic, and platelet disorders. Blood. 2019;134(23):2082-2091. doi:10.1182/blood.2018891192.

Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants. Genetics in Medicine. 2015;17(5):405-424. doi:10.1038/gim.2015.30.

Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the lea- ding causes of diagnostic error in haemostasis? Seminars in Thrombosis and Hemostasis. 2008;34(7):612-634. doi:10.1055/s-0028-1104540.

Mackie I, Cooper P, Lawrie A, et al. Guidelines on the laboratory aspects of assays used in ha- emostasis and thrombosis. International Journal of Laboratory Hematology. 2013;35(1):1-13.

Kitchen S, Olson JD, Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis. 2nd ed. Oxford: Wiley-Blackwell; 2013.

Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost. 2008 Nov;34(8):709- 33. doi: 10.1055/s-0029-1145254. Epub 2009 Feb 12. PMID: 19214910.

Larsen JB, Hvas AM, Hojbjerg JA. Platelet Function Testing: Update and Future Directions. Semin Thromb Hemost. 2023 Sep;49(6):600-608. doi: 10.1055/s-0042-1757898. Epub 2022 Nov 16. PMID: 36384230.

Munnix ICA, et al. Harmonizing light transmission aggregometry in the Netherlands by imp- lementation of the SSC-ISTH guideline. Platelets. 2021;32(4):516-523.

Kitchen S, Gray E, Mackie I, Baglin T, Makris M. Measurement of non-coumarin an- ticoagulants and their effects on tests of haemostasis. British Journal of Haematology. 2014;166(6):830-841.

Cuker A, Siegal DM, Crowther MA, Garcia DA. Laboratory measurement of the anticoagu- lant activity of the non-vitamin K oral anticoagulants. Journal of the American College of Cardiology. 2014;64(11):1128-1139.

Dunois C. Laboratory monitoring of direct oral anticoagulants. Biomedicines. 2021;9(5):445. doi:10.3390/biomedicines9050445.

Miller CH. Laboratory testing for factor VIII and IX inhibitors in haemophilia: a review. Ha- emophilia. 2018;24(2):186-197.

Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII inhibitors. Thrombosis and Haemostasis. 1995;73(2):247-251.

Chandler WL, Ferrell C, Trimble S, Moody S. Development of a rapid emergency hemorrhage panel. Transfusion. 2010;50(12):2547-2552.

Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measure- ment in clotting plasma. Pathophysiology of Haemostasis and Thrombosis. 2003;33(1):4-15.

de Laat-Kremers RMW, Ninivaggi M, Devreese KMJ, de Laat B. Towards standardization of thrombin generation assays: Inventory of thrombin generation methods based on results of an International Society of Thrombosis and Haemostasis Scientific Standardization Committee survey. J Thromb Haemost. 2020 Aug;18(8):1893-1899. doi: 10.1111/jth.14863. Epub 2020 Jun 3. PMID: 32319140.

Bastida JM, Lozano ML, Benito R, et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica. 2018;103(1):148-162.

Greinacher A, Eekels JJM. Diagnosis of hereditary platelet disorders in the era of next-gene- ration sequencing: “primum non nocere”. J Thromb Haemost. 2019 Mar;17(3):551-554. doi: 10.1111/jth.14377. Epub 2019 Feb 3. PMID: 30614196.

Megy K, Downes K, Simeoni I, et al; Subcommittee on Genomics in Thrombosis and Hemos- tasis. Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Commu- nication from the SSC of the ISTH. J Thromb Haemost. 2019 Aug;17(8):1253-1260. doi: 10.1111/jth.14479. Epub 2019 Jun 9. PMID: 31179617; PMCID: PMC6852472.

Pierce GF, et al. The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025. Haemophilia. 2026;32(1):20-54. doi:10.1111/hae.70113.

Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemop- hilia. 3rd ed. Haemophilia. 2020;26 Suppl 6:1-158.

Ní Áinle F, DiMichele D, Falck-Ytter Y, et al. ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Develop- ment, and Evaluation methodology: considerations for practice management and implementation. J Thromb Haemost. 2024 Sep;22(9):2404-2409. doi: 10.1016/j.jtha.2024.06.002. Epub 2024 Jun 20. PMID: 38908829.

Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Advances. 2021;5(1):301-325.

James PD, Flood VH, Connell NT. 2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on VWD. Blood Advances. 2025;9(14):3553-3555.

Platton S, et al. Guideline for laboratory diagnosis and monitoring of von Willebrand disease. Bri- tish Journal of Haematology. 2024.

Neunert CE, et al. The 2022 review of the 2019 ASH guidelines on immune thrombocytopenia. Blood Advances. 2024.

Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on primary immune thrombocytopenia. Blood Advances. 2019;3(22):3780-3817.

Zheng XL, Al-Housni Z, Cataland SR, et al; International Society on Thrombosis and Haemostasis. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocyto- penic purpura. J Thromb Haemost. 2025 Nov;23(11):3711-3732. doi: 10.1016/j.jtha.2025.06.002. Epub 2025 Jun 17. PMID: 40533296.

Scully M, Cataland SR, Peyvandi F, et al. Caplacizumab treatment for acquired TTP. New England Journal of Medicine. 2019;380:335-346.

George JN, Nester CM. Syndromes of thrombotic microangiopathy. New England Journal of Medi- cine. 2014;371:654-666.

Tiede A, Collins P, Knoebl P, et al. International recommendations on diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105(7):1791-1801.

Peyvandi F, Menegatti M. Treatment of rare factor deficiencies in 2016. Hematology Am Soc Hema- tol Educ Program. 2016 Dec 2;2016(1):663-669. doi: 10.1182/asheducation-2016.1.663. PMID: 27913544; PMCID: PMC6142507.

Gresele P, Bury L, Mezzasoma AM, Falcinelli E. Platelet function assays in diagnosis: an update.

Expert Rev Hematol. 2019 Jan;12(1):29-46. doi: 10.1080/17474086.2019.1562333. Epub 2019 Jan 16. PMID: 30571151.

Bastida JM, Lozano ML, Benito R, et al. Introducing high-throughput sequencing into mainstream

diagnosis of inherited platelet disorders. Haematologica. 2018;103:148-162.

Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in ITP. Blood. 2013.

Cuker A, Neunert CE. How I treat refractory immune thrombocytopenia. Blood. 2016.

Iba T, Levy JH, Warkentin TE, et al. Diagnosis and management of sepsis-induced coagulopathy

and DIC. Journal of Thrombosis and Haemostasis. 2019;17:1989-1994.

Taylor FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for DIC. Thrombosis and Haemostasis. 2001;86:1327-1330.

Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. New England Journal of Medicine. 2011;365:147-156.

Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease. Blood. 2010;116:878-885.

Hoffman R, et al. Hematology: Basic Principles and Practice. 8th ed. Elsevier; 2023.

Kaushansky K, et al. Williams Hematology. 11th ed. McGraw-Hill; 2025.

Wolberg AS, Rosendaal FR, Weitz JI, et al. Venous thrombosis. Nature Reviews Disease Pri- mers. 2015;1:15006.

Mackman N. New insights into the mechanisms of venous thrombosis. Journal of Clinical Investigation. 2012;122:2331-2336.

Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Natu- re Reviews Immunology. 2013;13:34-45.

Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Pro- ceedings of the National Academy of Sciences USA. 2010;107:15880-15885.

Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disea- se: second update of the CHEST guideline. Chest. 2021;160:e545-e608. doi:10.1016/j. chest.2021.07.055.

Ortel TL, Neumann I, Ageno W, et al. ASH 2020 guidelines for management of VTE: treat- ment of DVT and PE. Blood Advances. 2020;4:4693-4738.

Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for diagnosis and mana- gement of acute pulmonary embolism. European Heart Journal. 2020;41:543-603.

Creager MA, Barnes GD, Giri J, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/ SIR/SVM/SV N Guideline for the Evaluation and Management of Acute Pulmonary Em- bolism in Adults: A Report of the American College of Cardiology/American Heart As- sociation Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 Apr 7;87(13):1626-1710. doi: 10.1016/j.jacc.2025.11.005. Epub 2026 Feb 19. PMID: 41712898.

Ageno W, Beyer-Westendorf J, Garcia DA, et al. Guidance for management of venous throm- bosis in unusual sites. Journal of Thrombosis and Thrombolysis. 2016;41:129-143.

Canadian Stroke Best Practices. Cerebral Venous Thrombosis Module. 7th ed. 2024.

Valeriani E, Riva N, Di Nisio M, et al. Splanchnic Vein Thrombosis: Current Perspectives. Vasc Health Risk Manag. 2019 Oct 22;15:449-461. doi: 10.2147/VHRM.S197732. PMID: 31695400; PMCID: PMC6815215.

International Society on Thrombosis and Haemostasis. Guidance for management of venous thrombosis in cirrhosis. Journal of Thrombosis and Haemostasis. 2024.

American Society of Hematology. VTE Guidelines: Thrombophilia Testing. 2023.

Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classi- fication criteria. Annals of the Rheumatic Diseases. 2023;82:1258-1270.

British Society for Haematology. Cancer-associated venous thrombosis in adults. Second edi- tion. 2024.

Mazzolai L, Teixido-Tura G, Lanzi S, et al. 2024 ESC guidelines for management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45:3538-3700.

Cuker A, Arepally GM, Chong BH, et al. ASH 2018 guidelines for management of VTE: heparin-induced thrombocytopenia. Blood Advances. 2018;2:3360-3392.

May JE, Cuker A. Practical guide to diagnosis and management of heparin-induced thrombo- cytopenia. Hematology American Society of Hematology Education Program. 2024;2024:388- 398.

Greinacher A. Heparin-induced thrombocytopenia. New England Journal of Medicine. 2015;373:252-261.

Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Advances. 2020;4(19):4693-4738.

Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160(6):e545-e608.

Levy JH, Ageno W, Chan NC, et al. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 2024.

Tran HA, et al. 2025 guidelines for direct oral anticoagulants: practical guidance on prescrip- tion, laboratory testing, perioperative and bleeding management. Internal Medicine Journal. 2025.

Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of pa- tients with acute coronary syndromes. Journal of the American College of Cardiology. 2025.

Vrints C, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal. 2024.

Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Critical Care. 2023;27:80.

CRASH-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients. Lancet. 2010;376:23-32.

HALT-IT Trial Collaborators. Effects of a high-dose 24-hour infusion of tranexamic acid on death and thromboembolic events in acute gastrointestinal bleeding. Lancet. 2020;395:1927- 1936.

Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants. Journal of the American College of Cardiology. 2020;76:594-622.

Pollack CV Jr, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal. New England Journal of Medicine. 2017;377:431-441.

Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. New England Journal of Medicine. 2019;380:1326-1335.

Milling TJ Jr, et al. Andexanet alfa versus usual care in factor Xa inhibitor-associated intrac- ranial hemorrhage. New England Journal of Medicine. 2024.

Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine. 2015;162:205-213.

Roback JD, Caldwell S, Carson J, et al. Evidence-based practice guidelines for plasma trans- fusion. Transfusion. 2010;50:1227-1239.

Green L, et al. British Society for Haematology guideline on the spectrum of fresh frozen plasma and cryoprecipitate products. British Journal of Haematology. 2018.

Ranucci M, Aloisio T, Di Dedda U, et al. Fibrinogen and Prothrombin Complex Concent- rate: The Importance of the Temporal Sequence-A Post-Hoc Analysis of Two Randomized Controlled Trials. J Clin Med. 2024 Nov 25;13(23):7137. doi: 10.3390/jcm13237137. PMID: 39685596; PMCID: PMC11642716.

Casselman FPA, et al. 2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2025;67:ezae352.

Douketis JD, Spyropoulos AC, Murad MH, et al. Perioperative management of antithrom- botic therapy: an American College of Chest Physicians clinical practice guideline. Chest. 2022;162:e207-e243.

January CT, et al. 2023 ACC/AHA/ACCP/HRS guideline for diagnosis and management of atrial fibrillation. Circulation. 2024;149:e1-e156.

Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed. Chest. 2012;141 Suppl:7S-47S.

Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guideli- nes for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Advances. 2018;2(22):3317-3359. doi:10.1182/bloodadvances.2018024802.

American College of Obstetricians and Gynecologists. Practice Bulletin No. 196: Thrombo- embolism in Pregnancy. Obstetrics & Gynecology. 2018;132(1):e1-e17.

Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Throm- boembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. London: RCOG.

National Bleeding Disorders Foundation. MASAC Document 286: Recommendations Re- garding Diagnosis and Management of Inherited Bleeding Disorders in Girls and Women. 2024.

Samuelson Bannow B. Management of heavy menstrual bleeding on anticoagulation. Hema- tology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):533-537. doi: 10.1182/hemato- logy.2020000138. PMID: 33275699; PMCID: PMC7727540.

James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diag- nosis of von Willebrand disease. Blood Advances. 2021;5(1):280-300.

Monagle P, Azzam M, Bercovitz R, et al. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Blood Adv. 2025 May 27;9(10):2587-2636. doi: 10.1182/bloodadvances.2024015328. PMID: 40423983; PMCID: PMC12235321.

American Society of Hematology. VTE Guidelines: Pediatrics. 2025.

Douketis JD, Spyropoulos AC, Murad MH, et al. Perioperative Management of Antithrom- botic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2022;162(5):e207-e243.

Thompson A, et al. 2024 AHA/ACC Guideline for Perioperative Cardiovascular Manage- ment for Noncardiac Surgery. Circulation. 2024;150:e351-e442.

Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Critical Care. 2023;27:80. doi:10.1186/s13054-023-04327-7.

International Society on Thrombosis and Haemostasis. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the SSC. Journal of Thrombosis and Haemostasis.

Extracorporeal Life Support Organization. ELSO Guidelines for Adult and Pediatric Extra- corporeal Life Support. Ann Arbor: ELSO.

Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105 Suppl 4S:S117-S314.

Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. New England Journal of Medicine. 2011;365:147-156.

Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease. Blood. 2010;116:878- 885.

Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. PMID: 30482768; PMCID: PMC6258919.

World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: WHO.

Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on morta- lity in women with postpartum haemorrhage: WOMAN trial. Lancet. 2017;389:2105-2116.

CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients. Lancet. 2010;376:23-32.

Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131:845- 854.

Damanti S, Braham S, Pasina L. Anticoagulation in frail older people. J Geriatr Cardiol. 2019 Nov;16(11):844-846. doi: 10.11909/j.issn.1671-5411.2019.11.005. PMID: 31853251; PMCID: PMC6911797.

Steffel J, Collins R, Antz M, et al. European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23:1612-1676.

Kaatz S, Mahan CE, Nakhle A, Gunasekaran K, Ali M, Lavender R, Paje DG. Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants. Curr Cardiol Rep. 2017 Oct 24;19(12):124. doi: 10.1007/s11886-017-0930-2. PMID: 29064044.

Abdul-Kadir R, et al. Management of inherited bleeding disorders in pregnancy. BJOG. Gre- en-top Guideline No. 71.

Samuelson Bannow B. Management of heavy menstrual bleeding on anticoagulation. Hema- tology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):533-537. doi: 10.1182/hemato- logy.2020000138. PMID: 33275699; PMCID: PMC7727540.

Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):887S-968S. doi: 10.1378/chest.08-0762. PMID: 18574281.

Levy JH, Neal MD, Herman JH. Bacterial contamination of platelets for transfusion: strate- gies for prevention. Critical Care. 2018.

Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein th- rombosis, and procedural bleeding in patients with liver disease. Hepatology. 2021.

January CT, Wann LS, Calkins H, et al. Atrial fibrillation guideline update. Circulation. 2023.